Rheumatoid liver?

Kendall, M J; Cockel, R; Becker, J; Hawkins, C F
July 1970
British Medical Journal;7/25/1970, Vol. 3 Issue 5716, p221
Academic Journal
No abstract available.


Related Articles

  • Folates Help Arthritis Sufferers Stay On Methrotrexate.  // RN;Aug2002, Vol. 65 Issue 8, p21 

    Reports the effect of folates on rheumatoid arthritis. Reduction of liver enzyme elevations; Continuance of methotrexate administration; Adverse effects of methotrexate.

  • Methotrexate.  // Reactions Weekly;Feb2015, Vol. 1540 Issue 1, p200 

    The article presents several case studies of patients who developed liver damage after receiving methotrexate treatment for rheumatoid arthritis.

  • Liver Disease in Rheumatoid Arthritis. Ellman, Michael H.; Weis, Mervyn J.; Spellberg, Mitchell A. // American Journal of Gastroenterology;Jul1974, Vol. 62 Issue 1, p46 

    Presents a case report on patient with rheumatoid arthritis who developed liver disease. Findings from physical examination and laboratory test conducted on the patient; Features of the liver disease; Exploration of the factors inducing liver disease on the patient.

  • Literature reviews. Lampe, John B.; Jacobs, Jerry C. // Clinical Pediatrics;May1997, Vol. 36 Issue 5, p305 

    Presents a summary of the paper `Liver Biopsy Findings in Patients with Juvenile Rheumatoid Arthritis Receiving Long-Term, Weekly Methotrexate Therapy,' by Kugathasan S., Newman A., et al. Indications of liver biopsy; Efficacy of a weekly dosage of methotrexate for juvenile rheumatoid arthritis...

  • Rheumatoid Arthritis – Treatment [93–171].  // Rheumatology;Apr2008, Vol. 47, pii28 

    This section presents abstracts on topics related to the treatment of rheumatoid arthritis (RA) including the liver profile of patients with RA, treating rheumatoid associated with hypogammaglobulinaemia with tumor necrosis factor blockade and the survival of patients receiving intramuscular...

  • Re: J. M. Kremer--Editorial. Levin, Douglas M. // American Journal of Gastroenterology;Aug1997, Vol. 92 Issue 8, p1402 

    Presents a letter to the editor in response to the article "Liver Toxicity Does Not Have to Follow Methotrexate Therapy of Patients With Rheumatoid Arthritis," by J. M. Kremer in the 1997 issue.

  • Liver enzyme elevations uncommon with TNF-inhibitor use.  // Reactions Weekly;7/10/2010, Issue 1309, p3 

    The article discusses a research study which observed risk of elevated liver enzymes associated with the use of tumour necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis.

  • Adalimumab/etanercept.  // Reactions Weekly;2/18/2012, Issue 1389, p7 

    The article describes the case of a 47-year-old woman with rheumatoid arthritis who experienced recurrent liver injury while receiving treatment with etanercept and adalimumab.

  • Methotrexate.  // Reactions Weekly;8/11/2012, Issue 1414, p36 

    The article describes the cases of five patients who developed liver fibrosis and/or lobular inflammation during treatment with methotrexate for rheumatoid arthritis (RA).

  • Methotrexate.  // Reactions Weekly;2/2/2013, Issue 1437, p23 

    The article describes the case of a 26-year-old woman who developed portal hypertension and silent liver cirrhosis while receiving methotrexate for rheumatoid arthritis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics